| Teva Pharma AG - Doxorubicin-Teva 200 mg/100 ml, Injektionslösung |
| 59350 | | 04 | | Doxorubicin-Teva 200 mg/100 ml | | Injektionslösung | | L01DB01 | | Doxorubicin | | 02.12.2009 | | |
|
| Composition |
| doxorubicini hydrochloridum 200 mg, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 100 ml, natrium 355.16 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Doxorubicin Hydrochloride | 200mg / 100ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Chloride | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | Durchstechflasche(n) | | | A | | Yes |
|
